| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellularly ATP-gated monoatomic cation channel activity | 7.52e-08 | 7 | 138 | 4 | GO:0004931 | |
| GeneOntologyMolecularFunction | ATP-gated ion channel activity | 2.68e-07 | 9 | 138 | 4 | GO:0035381 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.04e-06 | 12 | 138 | 4 | GO:0001851 | |
| GeneOntologyMolecularFunction | complement binding | 2.54e-06 | 32 | 138 | 5 | GO:0001848 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 1.45e-05 | 22 | 138 | 4 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 1.45e-05 | 22 | 138 | 4 | GO:0001614 | |
| GeneOntologyMolecularFunction | opsonin binding | 2.47e-05 | 25 | 138 | 4 | GO:0001846 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 8.49e-05 | 323 | 138 | 10 | GO:1901681 | |
| GeneOntologyMolecularFunction | suramin binding | 1.42e-04 | 3 | 138 | 2 | GO:0043924 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.19e-04 | 43 | 138 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | TRAIL receptor activity | 2.82e-04 | 4 | 138 | 2 | GO:0036463 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.09e-04 | 85 | 138 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.37e-04 | 188 | 138 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 3.82e-04 | 192 | 138 | 7 | GO:0008201 | |
| GeneOntologyMolecularFunction | TRAIL binding | 4.68e-04 | 5 | 138 | 2 | GO:0045569 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 5.60e-04 | 268 | 138 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | ceramide 1-phosphate binding | 9.73e-04 | 7 | 138 | 2 | GO:1902387 | |
| GeneOntologyMolecularFunction | ceramide 1-phosphate transfer activity | 9.73e-04 | 7 | 138 | 2 | GO:1902388 | |
| GeneOntologyMolecularFunction | deSUMOylase activity | 9.73e-04 | 7 | 138 | 2 | GO:0016929 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | SELE FLT3 EPHA6 CRIM1 UNC5B IL20RB TNFRSF10B TNFRSF10A CR1L CR2 ADORA2B P2RX1 P2RX4 P2RX7 PTPRO P2RX2 TNFRSF8 ENG PLXNB1 EPHA3 | 1.01e-03 | 1353 | 138 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.07e-03 | 65 | 138 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | zinc ion binding | EPRS1 ENPP1 RNF19B ZMYND8 ZNF208 MDM4 P2RX4 P2RX7 ADAMTS9 P2RX2 TRIM8 ADAMTS20 KNG1 NUP153 WDFY1 | 1.29e-03 | 891 | 138 | 15 | GO:0008270 |
| GeneOntologyMolecularFunction | ceramide transfer activity | 1.29e-03 | 8 | 138 | 2 | GO:0120017 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.48e-03 | 120 | 138 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | protease binding | 1.63e-03 | 181 | 138 | 6 | GO:0002020 | |
| GeneOntologyMolecularFunction | sphingolipid transfer activity | 1.65e-03 | 9 | 138 | 2 | GO:0120016 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.00e-03 | 77 | 138 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | copper ion binding | 2.10e-03 | 78 | 138 | 4 | GO:0005507 | |
| GeneOntologyMolecularFunction | kinase activity | FLT3 VRK2 EPHA6 CRIM1 TRIO OBSCN MYO3A MASTL KHK POMK ENG EPHA3 CKMT1A | 2.48e-03 | 764 | 138 | 13 | GO:0016301 |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.87e-03 | 85 | 138 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | protein kinase activity | 3.03e-03 | 600 | 138 | 11 | GO:0004672 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 3.26e-03 | 43 | 138 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | structural molecule activity | FRAS1 VWF MYOM1 OBSCN LAMC3 TECTA KRT39 SPON1 MUC2 MUC5AC MUC6 NUP153 EPB42 MYBPC1 | 3.50e-03 | 891 | 138 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | FLT3 VRK2 EPHA6 CRIM1 TRIO OBSCN MYO3A MASTL KHK POMK ENG EPHA3 | 3.78e-03 | 709 | 138 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | complement receptor activity | 4.09e-03 | 14 | 138 | 2 | GO:0004875 | |
| GeneOntologyMolecularFunction | titin binding | 4.09e-03 | 14 | 138 | 2 | GO:0031432 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 8.62e-07 | 27 | 137 | 5 | GO:0030449 | |
| GeneOntologyBiologicalProcess | purinergic nucleotide receptor signaling pathway | 2.46e-06 | 33 | 137 | 5 | GO:0035590 | |
| GeneOntologyBiologicalProcess | response to ATP | 6.56e-06 | 40 | 137 | 5 | GO:0033198 | |
| GeneOntologyBiologicalProcess | complement activation | 7.12e-06 | 70 | 137 | 6 | GO:0006956 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 1.57e-05 | 8 | 137 | 3 | GO:0045959 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 3.32e-05 | 10 | 137 | 3 | GO:0030450 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | CFH VWF ENPP1 SVEP1 CFHR4 P2RX1 PTPRO CD40 ADAMTS18 PLAU MUC2 KNG1 | 4.01e-05 | 442 | 137 | 12 | GO:0050878 |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 4.89e-05 | 60 | 137 | 5 | GO:0002920 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 6.04e-05 | 12 | 137 | 3 | GO:0002924 | |
| GeneOntologyBiologicalProcess | blood coagulation | 6.16e-05 | 260 | 137 | 9 | GO:0007596 | |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase III | 6.20e-05 | 63 | 137 | 5 | GO:0006383 | |
| GeneOntologyBiologicalProcess | coagulation | 7.34e-05 | 266 | 137 | 9 | GO:0050817 | |
| GeneOntologyBiologicalProcess | leukocyte homeostasis | 7.40e-05 | 153 | 137 | 7 | GO:0001776 | |
| GeneOntologyBiologicalProcess | hemostasis | 7.77e-05 | 268 | 137 | 9 | GO:0007599 | |
| GeneOntologyBiologicalProcess | regulation of complement-dependent cytotoxicity | 7.81e-05 | 13 | 137 | 3 | GO:1903659 | |
| GeneOntologyBiologicalProcess | platelet activation | 9.06e-05 | 158 | 137 | 7 | GO:0030168 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 9.89e-05 | 14 | 137 | 3 | GO:0045916 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 1.51e-04 | 16 | 137 | 3 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 1.51e-04 | 16 | 137 | 3 | GO:0002890 | |
| GeneOntologyBiologicalProcess | complement-dependent cytotoxicity | 1.51e-04 | 16 | 137 | 3 | GO:0097278 | |
| GeneOntologyBiologicalProcess | inflammatory response | SELE CFH ATRN VWF IL25 ENPP1 TAFA3 IL20RB CR2 LDLR CD163 CFHR4 ADORA2B FASN P2RX1 P2RX7 CD40 KNG1 | 1.91e-04 | 1043 | 137 | 18 | GO:0006954 |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | CFH IL25 ENPP1 RNF19B IL20RB CR1L CR2 SVEP1 CFHR4 P2RX7 CD40 | 2.08e-04 | 449 | 137 | 11 | GO:0002449 |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 2.57e-04 | 19 | 137 | 3 | GO:0006957 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 2.57e-04 | 19 | 137 | 3 | GO:0002921 | |
| GeneOntologyBiologicalProcess | muscle cell development | 3.44e-04 | 259 | 137 | 8 | GO:0055001 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport into cytosol | 3.49e-04 | 21 | 137 | 3 | GO:0010524 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 3.76e-04 | 142 | 137 | 6 | GO:0046683 | |
| GeneOntologyBiologicalProcess | bone development | 3.91e-04 | 264 | 137 | 8 | GO:0060348 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 4.01e-04 | 334 | 137 | 9 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 4.01e-04 | 334 | 137 | 9 | GO:0001894 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 4.02e-04 | 22 | 137 | 3 | GO:0002923 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell-matrix adhesion | 4.32e-04 | 5 | 137 | 2 | GO:2000097 | |
| GeneOntologyBiologicalProcess | positive regulation of melanocyte differentiation | 4.32e-04 | 5 | 137 | 2 | GO:0045636 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | CFH IL25 ENPP1 RNF19B IL20RB CR1L CR2 SVEP1 CFHR4 ADORA2B P2RX7 CD40 | 4.69e-04 | 576 | 137 | 12 | GO:0002443 |
| GeneOntologyCellularComponent | external side of plasma membrane | SELE CFH FLT3 VWF CUBN TNFRSF10A CR1L CR2 LDLR CD163 CFHR4 P2RX1 P2RX7 CLEC4D CD40 PLAU ENG | 5.39e-08 | 519 | 137 | 17 | GO:0009897 |
| GeneOntologyCellularComponent | cell surface | SELE CFH RTP1 FLT3 VWF ENPP1 TNFRSF10B CUBN TNFRSF10A CR1L ELSPBP1 CR2 LDLR CD163 CFHR4 ADORA2B P2RX1 P2RX7 CLEC4D ADAMTS9 P2RX2 TEX101 CD40 PLAU ENG | 5.62e-08 | 1111 | 137 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | extracellular matrix | FRAS1 VWF LAMC3 ADAM11 TECTA SVEP1 EYS ADAMTS9 OTOGL GLG1 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 MUC2 MUC5AC MUC6 KNG1 | 2.99e-07 | 656 | 137 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FRAS1 VWF LAMC3 ADAM11 TECTA SVEP1 EYS ADAMTS9 OTOGL GLG1 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 MUC2 MUC5AC MUC6 KNG1 | 3.12e-07 | 658 | 137 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | side of membrane | SELE CFH FLT3 VWF CUBN TNFRSF10A TECTA CR1L CR2 LDLR CD163 CFHR4 STAC2 P2RX1 P2RX7 CLEC4D TEX101 CD40 PLAU ENG | 1.11e-06 | 875 | 137 | 20 | GO:0098552 |
| GeneOntologyCellularComponent | somatodendritic compartment | CFH PCSK5 EPHA6 AZIN2 ENPP1 PENK ZMYND8 NAP1L4 SPG11 ADAM11 LDLR CFHR4 TXN P2RX4 P2RX7 PTPRO P2RX2 RPTOR CD40 KNG1 EPHA3 CKMT1A | 1.58e-05 | 1228 | 137 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | myosin filament | 2.01e-05 | 25 | 137 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | neuronal cell body | CFH PCSK5 AZIN2 ENPP1 PENK NAP1L4 ADAM11 CFHR4 TXN P2RX4 P2RX7 P2RX2 RPTOR CD40 KNG1 CKMT1A | 1.18e-04 | 835 | 137 | 16 | GO:0043025 |
| GeneOntologyCellularComponent | mucus layer | 1.27e-04 | 3 | 137 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 2.54e-04 | 4 | 137 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | serine-type endopeptidase complex | 2.89e-04 | 20 | 137 | 3 | GO:1905370 | |
| GeneOntologyCellularComponent | serine-type peptidase complex | 3.87e-04 | 22 | 137 | 3 | GO:1905286 | |
| GeneOntologyCellularComponent | cell body | CFH PCSK5 AZIN2 ENPP1 PENK NAP1L4 ADAM11 CFHR4 TXN P2RX4 P2RX7 P2RX2 RPTOR CD40 KNG1 CKMT1A | 3.92e-04 | 929 | 137 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | membrane raft | 6.50e-04 | 362 | 137 | 9 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 6.76e-04 | 364 | 137 | 9 | GO:0098857 | |
| GeneOntologyCellularComponent | M band | 1.08e-03 | 31 | 137 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.16e-03 | 8 | 137 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 1.49e-03 | 9 | 137 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | dendrite | PCSK5 EPHA6 AZIN2 ENPP1 PENK ZMYND8 NAP1L4 SPG11 TXN P2RX4 PTPRO P2RX2 RPTOR EPHA3 | 1.53e-03 | 858 | 137 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | PCSK5 EPHA6 AZIN2 ENPP1 PENK ZMYND8 NAP1L4 SPG11 TXN P2RX4 PTPRO P2RX2 RPTOR EPHA3 | 1.56e-03 | 860 | 137 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.62e-03 | 530 | 137 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | plasma membrane raft | 2.85e-03 | 147 | 137 | 5 | GO:0044853 | |
| GeneOntologyCellularComponent | perikaryon | 3.55e-03 | 223 | 137 | 6 | GO:0043204 | |
| MousePheno | abnormal capillary morphology | 5.77e-06 | 93 | 104 | 7 | MP:0003658 | |
| MousePheno | increased acute inflammation | 3.00e-05 | 164 | 104 | 8 | MP:0005088 | |
| MousePheno | enhanced leukocyte tethering or rolling | 3.25e-05 | 9 | 104 | 3 | MP:0020333 | |
| MousePheno | abnormal hypersensitivity reaction | 4.58e-05 | 174 | 104 | 8 | MP:0002148 | |
| MousePheno | artery occlusion | 5.48e-05 | 2 | 104 | 2 | MP:0006134 | |
| MousePheno | abnormal hepatic portal vein thrombosis | 5.48e-05 | 2 | 104 | 2 | MP:0031159 | |
| MousePheno | white pupil | 5.48e-05 | 2 | 104 | 2 | MP:0006242 | |
| MousePheno | decreased serum complement activity | 5.48e-05 | 2 | 104 | 2 | MP:0012553 | |
| MousePheno | decreased complement C5 level | 5.48e-05 | 2 | 104 | 2 | MP:0012609 | |
| MousePheno | abnormal complement C5 level | 5.48e-05 | 2 | 104 | 2 | MP:0012608 | |
| MousePheno | abnormal acute inflammation | SELE CFH VWF IL25 IL20RB CFHR4 ADORA2B CLEC4D CD40 TRIM8 ADAMTS18 | 6.90e-05 | 357 | 104 | 11 | MP:0002498 |
| MousePheno | abnormal Bruch membrane morphology | 1.37e-04 | 14 | 104 | 3 | MP:0005239 | |
| MousePheno | abnormal kidney venous thrombosis | 1.64e-04 | 3 | 104 | 2 | MP:0031161 | |
| MousePheno | increased susceptilbility to retina ischemic injury | 1.64e-04 | 3 | 104 | 2 | MP:0012049 | |
| MousePheno | retina detachment | 1.71e-04 | 15 | 104 | 3 | MP:0003099 | |
| MousePheno | abnormal kidney vasculature morphology | 2.08e-04 | 73 | 104 | 5 | MP:0000530 | |
| MousePheno | abnormal intercellular signaling peptide or protein level | FLT3 IL25 TNFRSF10B TNFRSF10A LDLR CD163 ADORA2B CLEC4D SPON1 TRIM8 PLAU MUC5AC | 2.30e-04 | 480 | 104 | 12 | MP:0008835 |
| MousePheno | amyloid beta deposits | 2.52e-04 | 17 | 104 | 3 | MP:0003329 | |
| MousePheno | abnormal carotid artery morphology | 3.12e-04 | 44 | 104 | 4 | MP:0004181 | |
| MousePheno | increased susceptibility to type III hypersensitivity reaction | 3.26e-04 | 4 | 104 | 2 | MP:0005615 | |
| MousePheno | mesangial cell interposition | 3.26e-04 | 4 | 104 | 2 | MP:0011512 | |
| MousePheno | abnormal brain thrombosis | 3.26e-04 | 4 | 104 | 2 | MP:0031168 | |
| MousePheno | abnormal response to retina ischemic injury | 3.26e-04 | 4 | 104 | 2 | MP:0012048 | |
| MousePheno | fetal bleb | 3.26e-04 | 4 | 104 | 2 | MP:0008856 | |
| MousePheno | decreased circulating complement protein level | 3.26e-04 | 4 | 104 | 2 | MP:0020216 | |
| MousePheno | increased creatine level | 3.26e-04 | 4 | 104 | 2 | MP:0010061 | |
| MousePheno | abnormal glomerular capillary morphology | 4.03e-04 | 47 | 104 | 4 | MP:0011320 | |
| MousePheno | abnormal skin coloration | 4.15e-04 | 182 | 104 | 7 | MP:0011239 | |
| MousePheno | abnormal kidney capillary morphology | 4.37e-04 | 48 | 104 | 4 | MP:0011310 | |
| MousePheno | abnormal glomerular capillary endothelium morphology | 4.83e-04 | 21 | 104 | 3 | MP:0011453 | |
| MousePheno | abnormal venous thrombosis | 5.40e-04 | 5 | 104 | 2 | MP:0031158 | |
| MousePheno | abnormal lung thrombosis | 5.40e-04 | 5 | 104 | 2 | MP:0031167 | |
| MousePheno | decreased cellular sensitivity to gamma-irradiation | 5.56e-04 | 22 | 104 | 3 | MP:0003207 | |
| MousePheno | abnormal optic choroid morphology | 5.95e-04 | 52 | 104 | 4 | MP:0005098 | |
| MousePheno | internal hemorrhage | 6.08e-04 | 387 | 104 | 10 | MP:0001634 | |
| MousePheno | absent kidney | 6.40e-04 | 53 | 104 | 4 | MP:0000520 | |
| MousePheno | abnormal cytokine level | FLT3 IL25 TNFRSF10B TNFRSF10A LDLR CD163 ADORA2B CLEC4D TRIM8 PLAU MUC5AC | 7.36e-04 | 470 | 104 | 11 | MP:0008713 |
| MousePheno | abnormal circulating complement protein level | 8.06e-04 | 6 | 104 | 2 | MP:0010215 | |
| MousePheno | telangiectasia | 8.06e-04 | 6 | 104 | 2 | MP:0004175 | |
| Domain | EGF | SELE PCSK5 ATRN FRAS1 LAMC3 ADAM11 CUBN TECTA LDLR SVEP1 EYS SUSD1 ATRNL1 SLIT3 TENM1 PLAU | 1.29e-11 | 235 | 134 | 16 | SM00181 |
| Domain | EGF-like_dom | SELE PCSK5 ATRN FRAS1 LAMC3 ADAM11 CUBN TECTA LDLR SVEP1 EYS SUSD1 ATRNL1 SLIT3 TENM1 PLAU | 3.09e-11 | 249 | 134 | 16 | IPR000742 |
| Domain | VWC_out | 3.92e-11 | 19 | 134 | 7 | SM00215 | |
| Domain | Growth_fac_rcpt_ | PCSK5 ATRN FRAS1 EPHA6 CRIM1 LAMC3 CUBN LDLR SVEP1 EYS SUSD1 SLIT3 EPHA3 | 9.63e-11 | 156 | 134 | 13 | IPR009030 |
| Domain | Sushi | 3.28e-09 | 52 | 134 | 8 | PF00084 | |
| Domain | CCP | 4.48e-09 | 54 | 134 | 8 | SM00032 | |
| Domain | SUSHI | 6.05e-09 | 56 | 134 | 8 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 6.99e-09 | 57 | 134 | 8 | IPR000436 | |
| Domain | EGF_2 | SELE ATRN LAMC3 ADAM11 CUBN LDLR SVEP1 EYS SUSD1 ATRNL1 SLIT3 TENM1 PLAU EPHA3 | 7.13e-09 | 265 | 134 | 14 | PS01186 |
| Domain | C8 | 1.34e-08 | 12 | 134 | 5 | PF08742 | |
| Domain | TIL | 1.34e-08 | 12 | 134 | 5 | PF01826 | |
| Domain | TSP_1 | THSD7A UNC5B THSD7B ADAMTS9 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 | 1.58e-08 | 63 | 134 | 8 | PF00090 |
| Domain | VWF_dom | 1.83e-08 | 42 | 134 | 7 | IPR001007 | |
| Domain | TSP1 | THSD7A UNC5B THSD7B ADAMTS9 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 | 2.04e-08 | 65 | 134 | 8 | SM00209 |
| Domain | TSP1_rpt | THSD7A UNC5B THSD7B ADAMTS9 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 | 2.04e-08 | 65 | 134 | 8 | IPR000884 |
| Domain | TSP1 | THSD7A UNC5B THSD7B ADAMTS9 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 | 2.04e-08 | 65 | 134 | 8 | PS50092 |
| Domain | Unchr_dom_Cys-rich | 2.17e-08 | 13 | 134 | 5 | IPR014853 | |
| Domain | C8 | 2.17e-08 | 13 | 134 | 5 | SM00832 | |
| Domain | TIL_dom | 3.35e-08 | 14 | 134 | 5 | IPR002919 | |
| Domain | EGF_1 | SELE ATRN LAMC3 ADAM11 CUBN LDLR SVEP1 EYS SUSD1 ATRNL1 SLIT3 TENM1 PLAU | 3.85e-08 | 255 | 134 | 13 | PS00022 |
| Domain | EGF-like_CS | SELE ATRN LAMC3 ADAM11 CUBN LDLR SVEP1 EYS SUSD1 ATRNL1 SLIT3 TENM1 PLAU | 5.07e-08 | 261 | 134 | 13 | IPR013032 |
| Domain | VWF_type-D | 7.23e-08 | 16 | 134 | 5 | IPR001846 | |
| Domain | VWFD | 7.23e-08 | 16 | 134 | 5 | PS51233 | |
| Domain | VWD | 7.23e-08 | 16 | 134 | 5 | SM00216 | |
| Domain | VWD | 7.23e-08 | 16 | 134 | 5 | PF00094 | |
| Domain | P2X_receptor | 8.72e-08 | 7 | 134 | 4 | PF00864 | |
| Domain | P2X_purnocptor | 8.72e-08 | 7 | 134 | 4 | IPR001429 | |
| Domain | - | 8.72e-08 | 7 | 134 | 4 | 2.60.490.10 | |
| Domain | P2X_RECEPTOR | 8.72e-08 | 7 | 134 | 4 | PS01212 | |
| Domain | P2X_extracellular_dom | 8.72e-08 | 7 | 134 | 4 | IPR027309 | |
| Domain | EGF_3 | SELE ATRN ADAM11 CUBN LDLR SVEP1 EYS SUSD1 ATRNL1 SLIT3 TENM1 PLAU | 1.30e-07 | 235 | 134 | 12 | PS50026 |
| Domain | VWFC_2 | 2.79e-07 | 38 | 134 | 6 | PS50184 | |
| Domain | VWC | 2.79e-07 | 38 | 134 | 6 | SM00214 | |
| Domain | CT | 4.21e-07 | 22 | 134 | 5 | SM00041 | |
| Domain | Ephrin_rec_like | 8.35e-07 | 25 | 134 | 5 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 8.35e-07 | 25 | 134 | 5 | IPR011641 | |
| Domain | Cys_knot_C | 8.35e-07 | 25 | 134 | 5 | IPR006207 | |
| Domain | CTCK_2 | 8.35e-07 | 25 | 134 | 5 | PS01225 | |
| Domain | VWFC_1 | 5.56e-06 | 36 | 134 | 5 | PS01208 | |
| Domain | CTCK_1 | 7.17e-06 | 18 | 134 | 4 | PS01185 | |
| Domain | Pep_M12B_propep | 8.35e-06 | 39 | 134 | 5 | PF01562 | |
| Domain | Peptidase_M12B_N | 8.35e-06 | 39 | 134 | 5 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 9.49e-06 | 40 | 134 | 5 | PS00427 | |
| Domain | Reprolysin | 9.49e-06 | 40 | 134 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 9.49e-06 | 40 | 134 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 9.49e-06 | 40 | 134 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 9.49e-06 | 40 | 134 | 5 | IPR001590 | |
| Domain | KRAB | ZNF570 ZNF316 ZNF208 ZNF587B ZNF250 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 ZNF726 | 1.06e-05 | 358 | 134 | 12 | PS50805 |
| Domain | KRAB | ZNF570 ZNF316 ZNF208 ZNF587B ZNF250 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 ZNF726 | 1.06e-05 | 358 | 134 | 12 | PF01352 |
| Domain | Disintegrin_dom | 1.07e-05 | 41 | 134 | 5 | IPR001762 | |
| Domain | KRAB | ZNF570 ZNF316 ZNF208 ZNF587B ZNF250 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 ZNF726 | 1.43e-05 | 369 | 134 | 12 | SM00349 |
| Domain | KRAB | ZNF570 ZNF316 ZNF208 ZNF587B ZNF250 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 ZNF726 | 1.47e-05 | 370 | 134 | 12 | IPR001909 |
| Domain | TNFR_c6 | 1.68e-05 | 22 | 134 | 4 | PF00020 | |
| Domain | ADAM_spacer1 | 2.02e-05 | 23 | 134 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.02e-05 | 23 | 134 | 4 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.41e-05 | 24 | 134 | 4 | IPR013273 | |
| Domain | - | ZNF570 ZNF316 ZNF208 ZXDA ZNF587B ZXDB ZNF250 OVOL1 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 PRDM15 ZNF726 | 2.94e-05 | 679 | 134 | 16 | 3.30.160.60 |
| Domain | TNFR | 3.35e-05 | 26 | 134 | 4 | SM00208 | |
| Domain | EGF | 3.47e-05 | 126 | 134 | 7 | PF00008 | |
| Domain | zf-C2H2 | ZNF570 ZNF316 ZNF208 ZXDA ZNF587B ZXDB ZNF250 OVOL1 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 PRDM15 ZNF726 | 3.76e-05 | 693 | 134 | 16 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF570 ZNF316 ZNF208 ZXDA ZNF587B ZXDB ZNF250 OVOL1 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 PRDM15 ZNF726 | 3.83e-05 | 694 | 134 | 16 | IPR013087 |
| Domain | VWC | 4.54e-05 | 28 | 134 | 4 | PF00093 | |
| Domain | Pept_M12B_GON-ADAMTSs | 5.11e-05 | 2 | 134 | 2 | IPR012314 | |
| Domain | GON | 5.11e-05 | 2 | 134 | 2 | PS51046 | |
| Domain | GON | 5.11e-05 | 2 | 134 | 2 | PF08685 | |
| Domain | TNFR_NGFR_1 | 5.23e-05 | 29 | 134 | 4 | PS00652 | |
| Domain | TNFR_NGFR_2 | 5.23e-05 | 29 | 134 | 4 | PS50050 | |
| Domain | Ephrin_rec_like | 5.71e-05 | 11 | 134 | 3 | PF07699 | |
| Domain | EGF_extracell | 7.02e-05 | 60 | 134 | 5 | IPR013111 | |
| Domain | EGF_2 | 7.02e-05 | 60 | 134 | 5 | PF07974 | |
| Domain | EGF_Ca-bd_CS | 7.06e-05 | 97 | 134 | 6 | IPR018097 | |
| Domain | EGF_CA | 7.91e-05 | 99 | 134 | 6 | PS01187 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 8.82e-05 | 33 | 134 | 4 | IPR001368 | |
| Domain | zf-C2H2_6 | ZNF570 ZNF316 ZNF208 ZNF250 ZNF43 ZNF587 ZNF814 ZNF418 ZNF417 ZNF726 | 9.07e-05 | 314 | 134 | 10 | PF13912 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.16e-04 | 106 | 134 | 6 | IPR000152 | |
| Domain | PLAC | 1.24e-04 | 14 | 134 | 3 | PF08686 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF570 ZNF316 ZNF208 ZXDA ZNF587B ZXDB ZNF250 OVOL1 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 PRDM15 ZNF726 | 1.39e-04 | 775 | 134 | 16 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF570 ZNF316 ZNF208 ZXDA ZNF587B ZXDB ZNF250 OVOL1 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 PRDM15 ZNF726 | 1.44e-04 | 777 | 134 | 16 | PS00028 |
| Domain | fn3 | 1.69e-04 | 162 | 134 | 7 | PF00041 | |
| Domain | Znf_C2H2-like | ZNF570 ZNF316 ZNF208 ZXDA ZNF587B ZXDB ZNF250 OVOL1 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 PRDM15 ZNF726 | 1.89e-04 | 796 | 134 | 16 | IPR015880 |
| Domain | Znf_C2H2 | ZNF570 ZNF316 ZNF208 ZXDA ZNF587B ZXDB ZNF250 OVOL1 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 PRDM15 ZNF726 | 2.15e-04 | 805 | 134 | 16 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF570 ZNF316 ZNF208 ZXDA ZNF587B ZXDB ZNF250 OVOL1 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 PRDM15 ZNF726 | 2.24e-04 | 808 | 134 | 16 | SM00355 |
| Domain | EGF_CA | 2.49e-04 | 122 | 134 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.72e-04 | 124 | 134 | 6 | IPR001881 | |
| Domain | - | 2.92e-04 | 81 | 134 | 5 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 2.92e-04 | 81 | 134 | 5 | IPR024079 | |
| Domain | GLTP | 3.04e-04 | 4 | 134 | 2 | PF08718 | |
| Domain | Glycolipid_transfer_prot_dom | 3.04e-04 | 4 | 134 | 2 | IPR014830 | |
| Domain | TNFR_10 | 3.04e-04 | 4 | 134 | 2 | IPR020465 | |
| Domain | PLAC | 3.22e-04 | 19 | 134 | 3 | PS50900 | |
| Domain | PLAC | 3.22e-04 | 19 | 134 | 3 | IPR010909 | |
| Domain | FN3 | 3.81e-04 | 185 | 134 | 7 | SM00060 | |
| Domain | FN3 | 5.89e-04 | 199 | 134 | 7 | PS50853 | |
| Domain | ZINC_PROTEASE | 7.02e-04 | 98 | 134 | 5 | PS00142 | |
| Domain | WxxW_domain | 7.52e-04 | 6 | 134 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 7.52e-04 | 6 | 134 | 2 | PF13330 | |
| Domain | ASX_HYDROXYL | 7.70e-04 | 100 | 134 | 5 | PS00010 | |
| Domain | FN3_dom | 7.86e-04 | 209 | 134 | 7 | IPR003961 | |
| Domain | DEATH | 9.31e-04 | 27 | 134 | 3 | SM00005 | |
| Domain | - | FLT3 EPHA6 MYOM1 TRIO UNC5B OBSCN SIGLEC14 IL20RB PTPRO PLXNB1 EPB42 EPHA3 MYBPC1 | 9.75e-04 | 663 | 134 | 13 | 2.60.40.10 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | THSD7A THSD7B ADAMTS9 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 POMK MUC2 MUC5AC MUC6 | 5.90e-10 | 109 | 107 | 11 | MM15164 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | THSD7A THSD7B ADAMTS9 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 MUC5AC MUC6 | 2.02e-09 | 68 | 107 | 9 | M27303 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | THSD7A THSD7B ADAMTS9 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 POMK MUC5AC MUC6 | 1.13e-08 | 111 | 107 | 10 | M27416 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.50e-08 | 39 | 107 | 7 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.50e-08 | 39 | 107 | 7 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | THSD7A THSD7B ADAMTS9 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 MUC5AC MUC6 | 1.36e-06 | 143 | 107 | 9 | M27275 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 1.48e-06 | 12 | 107 | 4 | M47953 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.13e-06 | 13 | 107 | 4 | MM14553 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | THSD7A THSD7B CUBN ADAMTS9 SPON1 ADAMTS16 ADAMTS18 ADAMTS20 KHK MUC5AC MUC6 | 3.03e-06 | 250 | 107 | 11 | M27554 |
| Pathway | WP_PURINERGIC_SIGNALING | 4.60e-06 | 33 | 107 | 5 | M39855 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 5.32e-06 | 16 | 107 | 4 | M26945 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 8.36e-06 | 6 | 107 | 3 | M47880 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.81e-05 | 27 | 107 | 4 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.58e-05 | 28 | 107 | 4 | M924 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 7.63e-05 | 58 | 107 | 5 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 8.29e-05 | 59 | 107 | 5 | M48343 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 8.85e-05 | 96 | 107 | 6 | M39581 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS | 8.90e-05 | 12 | 107 | 3 | M27631 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 1.75e-04 | 69 | 107 | 5 | M16894 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 5.12e-04 | 21 | 107 | 3 | MM15706 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNFSF10_RIPK1_3_SIGNALING_PATHWAY | 5.62e-04 | 5 | 107 | 2 | M49027 | |
| Pathway | REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION | 9.73e-04 | 26 | 107 | 3 | M29838 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY | 9.73e-04 | 26 | 107 | 3 | M27434 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 9.73e-04 | 26 | 107 | 3 | M27483 | |
| Pubmed | 6.75e-10 | 75 | 138 | 8 | 20637190 | ||
| Pubmed | 1.18e-09 | 5 | 138 | 4 | 20962256 | ||
| Pubmed | 3.54e-09 | 6 | 138 | 4 | 12270951 | ||
| Pubmed | Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. | 8.23e-09 | 7 | 138 | 4 | 33125712 | |
| Pubmed | Membrane compartments and purinergic signalling: occurrence and function of P2X receptors in lung. | 8.23e-09 | 7 | 138 | 4 | 19076210 | |
| Pubmed | 8.23e-09 | 7 | 138 | 4 | 18657557 | ||
| Pubmed | Go it alone no more--P2X7 joins the society of heteromeric ATP-gated receptor channels. | 8.23e-09 | 7 | 138 | 4 | 17895406 | |
| Pubmed | Genetic organization of complement receptor-related genes in the mouse. | 1.64e-08 | 8 | 138 | 4 | 2564419 | |
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 18825309 | ||
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 19828624 | ||
| Pubmed | Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. | 6.11e-08 | 3 | 138 | 3 | 19552691 | |
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 18300795 | ||
| Pubmed | Role of adenosine 5'-triphosphate in regulating renal microvascular function and in hypertension. | 6.11e-08 | 3 | 138 | 3 | 21768526 | |
| Pubmed | Two factor H-related proteins from the mouse: expression analysis and functional characterization. | 6.11e-08 | 3 | 138 | 3 | 17028856 | |
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 32805257 | ||
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 25684976 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 27165610 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 36793547 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 23807779 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 20699225 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 33154304 | ||
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 2.44e-07 | 4 | 138 | 3 | 24901817 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 36367122 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 17471237 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 14984930 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 16507336 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 2.44e-07 | 4 | 138 | 3 | 29869461 | |
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 2.44e-07 | 4 | 138 | 3 | 20929551 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 37499656 | ||
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 2.44e-07 | 4 | 138 | 3 | 27298226 | |
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 2.44e-07 | 4 | 138 | 3 | 17401217 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 12676567 | ||
| Pubmed | Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+. | 2.44e-07 | 4 | 138 | 3 | 23959888 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 25298197 | ||
| Pubmed | Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. | 6.08e-07 | 5 | 138 | 3 | 1689298 | |
| Pubmed | C3-dependent mechanism of microglial priming relevant to multiple sclerosis. | 6.08e-07 | 5 | 138 | 3 | 22219359 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 9799332 | ||
| Pubmed | A radiation hybrid map of complement factor H and factor H-related genes. | 6.08e-07 | 5 | 138 | 3 | 10380701 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 20675597 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 28428949 | ||
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 6.08e-07 | 5 | 138 | 3 | 16475027 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 20042240 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 22261707 | ||
| Pubmed | 6.87e-07 | 181 | 138 | 8 | 37372979 | ||
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 19110483 | ||
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 17982272 | ||
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 27196323 | ||
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 17438673 | ||
| Pubmed | 1.64e-06 | 22 | 138 | 4 | 15301860 | ||
| Pubmed | Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation. | 2.11e-06 | 7 | 138 | 3 | 28057640 | |
| Pubmed | 2.11e-06 | 7 | 138 | 3 | 19861685 | ||
| Pubmed | The regulation of the complement system: insights from genetically-engineered mice. | 2.11e-06 | 7 | 138 | 3 | 12914820 | |
| Pubmed | 3.85e-06 | 59 | 138 | 5 | 31351040 | ||
| Pubmed | 4.51e-06 | 28 | 138 | 4 | 33953184 | ||
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 18947875 | ||
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 20059470 | ||
| Pubmed | FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation. | 5.05e-06 | 9 | 138 | 3 | 28533443 | |
| Pubmed | Typing recombinant inbred mouse strains for microsatellite markers. | 5.05e-06 | 9 | 138 | 3 | 8507976 | |
| Pubmed | 5.78e-06 | 64 | 138 | 5 | 22261194 | ||
| Pubmed | 6.69e-06 | 415 | 138 | 10 | 16385451 | ||
| Pubmed | EPRS1 VPS39 OBSCN CUBN LDLR P2RX4 P2RX7 GLG1 DNAAF10 ATRNL1 MASTL ADAMTS18 ZNF726 PLXNB1 NUP153 WDFY1 | 6.78e-06 | 1084 | 138 | 16 | 11544199 | |
| Pubmed | Circulating AIM prevents hepatocellular carcinoma through complement activation. | 7.19e-06 | 10 | 138 | 3 | 25284781 | |
| Pubmed | Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. | 7.19e-06 | 10 | 138 | 3 | 8422330 | |
| Pubmed | 7.62e-06 | 117 | 138 | 6 | 17145500 | ||
| Pubmed | 9.85e-06 | 11 | 138 | 3 | 20301541 | ||
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 9.85e-06 | 11 | 138 | 3 | 23204401 | |
| Pubmed | 9.85e-06 | 11 | 138 | 3 | 33909046 | ||
| Pubmed | 1.00e-05 | 34 | 138 | 4 | 32553152 | ||
| Pubmed | Expression of the Bcl-2 protein BAD promotes prostate cancer growth. | 1.00e-05 | 34 | 138 | 4 | 19593445 | |
| Pubmed | 1.17e-05 | 126 | 138 | 6 | 17897319 | ||
| Pubmed | Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential. | 1.31e-05 | 12 | 138 | 3 | 29436413 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.31e-05 | 12 | 138 | 3 | 25770910 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 11862476 | ||
| Pubmed | Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2. | 1.56e-05 | 2 | 138 | 2 | 22341463 | |
| Pubmed | Absence of complement factor H reduces physical performance in C57BL6 mice. | 1.56e-05 | 2 | 138 | 2 | 32962822 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35254644 | ||
| Pubmed | Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. | 1.56e-05 | 2 | 138 | 2 | 20538999 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23991205 | ||
| Pubmed | Inheritance, hormonal regulation and properties of polymorphic murine antigens Mud1 and Mud2. | 1.56e-05 | 2 | 138 | 2 | 4992636 | |
| Pubmed | Retinal changes precede visual dysfunction in the complement factor H knockout mouse. | 1.56e-05 | 2 | 138 | 2 | 23844226 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31921199 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26374608 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19643115 | ||
| Pubmed | A gene locus concerned with an antigenic serum substance in Mus musculus. | 1.56e-05 | 2 | 138 | 2 | 4955525 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 2533512 | ||
| Pubmed | Complement factor H: spatial and temporal expression and localization in the eye. | 1.56e-05 | 2 | 138 | 2 | 16936129 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20430723 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18487206 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33558624 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 37940659 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19620346 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30705315 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22451435 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20694013 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23303206 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33859044 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 14722245 | ||
| Pubmed | Regulation of age-related macular degeneration-like pathology by complement factor H. | 1.56e-05 | 2 | 138 | 2 | 25991857 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28321513 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21899776 | ||
| Interaction | ZNF547 interactions | 4.67e-06 | 17 | 138 | 4 | int:ZNF547 | |
| Interaction | ST14 interactions | 1.31e-05 | 207 | 138 | 9 | int:ST14 | |
| Cytoband | 1q32 | 3.91e-07 | 49 | 138 | 5 | 1q32 | |
| Cytoband | 19q13.43 | 6.92e-06 | 87 | 138 | 5 | 19q13.43 | |
| Cytoband | 11p15.5 | 4.60e-04 | 118 | 138 | 4 | 11p15.5 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.02e-09 | 57 | 102 | 8 | 1179 | |
| GeneFamily | Purinergic receptors P2X | 3.30e-08 | 7 | 102 | 4 | 214 | |
| GeneFamily | Complement system|Sushi domain containing | 1.70e-06 | 36 | 102 | 5 | 492 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF570 ZNF316 ZNF208 ZXDA ZNF587B ZXDB ZNF250 OVOL1 ZNF43 ZNF587 ZNF814 ZNF552 ZNF418 ZNF417 PRDM15 ZNF726 | 2.54e-06 | 718 | 102 | 16 | 28 |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.47e-06 | 19 | 102 | 4 | 50 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 2.03e-05 | 29 | 102 | 4 | 782 | |
| GeneFamily | Fibronectin type III domain containing | 3.40e-05 | 160 | 102 | 7 | 555 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | SELE FLT3 TNFRSF10B TNFRSF10A CR2 CD163 CLEC4D TNFRSF8 CD40 ENG | 7.72e-05 | 394 | 102 | 10 | 471 |
| GeneFamily | CD molecules|Mucins | 2.15e-04 | 21 | 102 | 3 | 648 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 8.63e-04 | 8 | 102 | 2 | 658 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.59e-03 | 41 | 102 | 3 | 1298 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.19e-03 | 161 | 102 | 5 | 593 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.74e-03 | 14 | 102 | 2 | 1095 | |
| Coexpression | NABA_MATRISOME | PCSK5 FRAS1 VWF CRIM1 IL25 LAMC3 ADAM11 TECTA ELSPBP1 SVEP1 EYS CLEC4D ADAMTS9 SPON1 SLIT3 ADAMTS16 ADAMTS18 ADAMTS20 PLAU MUC2 MUC5AC MUC6 KNG1 PLXNB1 | 8.00e-10 | 1026 | 138 | 24 | M5889 |
| Coexpression | NABA_MATRISOME | PCSK5 FRAS1 VWF CRIM1 IL25 LAMC3 ADAM11 TECTA SVEP1 CLEC4D ADAMTS9 OTOGL SPON1 SLIT3 ADAMTS16 ADAMTS18 ADAMTS20 PLAU MUC2 MUC5AC MUC6 KNG1 PLXNB1 | 3.02e-09 | 1008 | 138 | 23 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 9.37e-08 | 196 | 138 | 10 | M3008 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.19e-07 | 191 | 138 | 9 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 2.09e-06 | 275 | 138 | 10 | M5884 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP | 1.10e-05 | 199 | 138 | 8 | M7656 | |
| Coexpression | NABA_CORE_MATRISOME | 1.38e-05 | 270 | 138 | 9 | MM17057 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | PCSK5 ENPP1 ZMYND8 SVEP1 FASN CROT ZNF43 ATRNL1 ZNF587 SLIT3 ZNF552 MUC6 PLXNB1 EPHA3 | 2.03e-05 | 699 | 138 | 14 | M4960 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 IL25 ADAM11 CLEC4D ADAMTS9 ADAMTS16 ADAMTS18 ADAMTS20 PLAU MUC2 MUC5AC MUC6 KNG1 PLXNB1 | 3.67e-05 | 738 | 138 | 14 | MM17058 |
| Coexpression | NABA_ECM_REGULATORS | 3.95e-05 | 238 | 138 | 8 | M3468 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 IL25 ADAM11 CLEC4D ADAMTS9 ADAMTS16 ADAMTS18 ADAMTS20 PLAU MUC2 MUC5AC MUC6 KNG1 PLXNB1 | 4.43e-05 | 751 | 138 | 14 | M5885 |
| Coexpression | NABA_ECM_REGULATORS | 4.45e-05 | 242 | 138 | 8 | MM17062 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | CFH VRK2 TRIO VPS39 ENPP1 RNF19B CUBN SVEP1 PTPRO MUC6 EPB42 | 5.13e-05 | 482 | 138 | 11 | M12144 |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN | 9.45e-05 | 200 | 138 | 7 | M7646 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN | 9.45e-05 | 200 | 138 | 7 | M5228 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN | 9.45e-05 | 200 | 138 | 7 | M6949 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP | 1.30e-04 | 19 | 138 | 3 | M12084 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-08 | 167 | 138 | 8 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-07 | 191 | 138 | 8 | 27a532a35d9e8822014f581fd56c4ca62e39f8fe | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-07 | 191 | 138 | 8 | 1dfcff08e01e6a695953334342bcfde04ba005ad | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-07 | 198 | 138 | 8 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.99e-07 | 198 | 138 | 8 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.99e-07 | 198 | 138 | 8 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-07 | 199 | 138 | 8 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-06 | 170 | 138 | 7 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-06 | 170 | 138 | 7 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.47e-06 | 179 | 138 | 7 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.64e-06 | 182 | 138 | 7 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-06 | 183 | 138 | 7 | 7961e05c6e9964da159059c6bfb4f7e7e14308c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-06 | 185 | 138 | 7 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.96e-06 | 187 | 138 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.96e-06 | 187 | 138 | 7 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.03e-06 | 188 | 138 | 7 | 263169029293e005bcffd87db20221fdd2d3917e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | d9c2adbbe3e40eb8d57200b6411533e6685ea0d2 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | 1d4ad307c0606957dd7bf8da84450e5193cf4a50 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | b952026044d5f6c0adce60cf24f6e0199e6f8757 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | 476226787c8ea0c9834a6f4c99ac7091cc20a455 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.10e-06 | 189 | 138 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | 3fe69bad6427e41b8d2dae450828cc21e9c3b3ad | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.26e-06 | 191 | 138 | 7 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 191 | 138 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.26e-06 | 191 | 138 | 7 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 191 | 138 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-06 | 192 | 138 | 7 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-06 | 192 | 138 | 7 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.34e-06 | 192 | 138 | 7 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.34e-06 | 192 | 138 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-06 | 192 | 138 | 7 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.42e-06 | 193 | 138 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 194 | 138 | 7 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 194 | 138 | 7 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 194 | 138 | 7 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.50e-06 | 194 | 138 | 7 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-06 | 196 | 138 | 7 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-06 | 196 | 138 | 7 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.68e-06 | 196 | 138 | 7 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-06 | 196 | 138 | 7 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-06 | 196 | 138 | 7 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-06 | 197 | 138 | 7 | 98e34e8612f111bb667a574de1faaa785d318ca4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-06 | 197 | 138 | 7 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-06 | 197 | 138 | 7 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass | 2.86e-06 | 198 | 138 | 7 | 5228c4bf2513186140c2c4eaa67a268c732bdc84 | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural|World / Primary Cells by Cluster | 2.86e-06 | 198 | 138 | 7 | 9fc1035ea447a4551a66944c869c4671e17cec61 | |
| ToppCell | Non-neuronal-Postmitotic-Mural|World / Primary Cells by Cluster | 2.86e-06 | 198 | 138 | 7 | dd38840a96171f58da243daa22b013e15a81db4a | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural-18|World / Primary Cells by Cluster | 2.86e-06 | 198 | 138 | 7 | 21efb7bcd24f24d20791b34e75d6f9d46a129481 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.96e-06 | 199 | 138 | 7 | bd9090c13a38a35d50f676fdf11b68eec1340bd3 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-06 | 199 | 138 | 7 | 0d63da0afa93741c37609d879941de202d9ac86c | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.96e-06 | 199 | 138 | 7 | ddd6cad854d889d58c1e6bbcdfd96edce4fc9694 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.96e-06 | 199 | 138 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-06 | 200 | 138 | 7 | e6d36be0c4c569e27303bb4e4f34cd2187e9759d | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.06e-06 | 200 | 138 | 7 | c0c51719cf81512c50bfcc2fed883c867e522d2a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 200 | 138 | 7 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.06e-06 | 200 | 138 | 7 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.06e-06 | 200 | 138 | 7 | 758840c31f2ddd7ccf7bf13252ebb48d33e89479 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.06e-06 | 200 | 138 | 7 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.06e-06 | 200 | 138 | 7 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.06e-06 | 200 | 138 | 7 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-06 | 200 | 138 | 7 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-06 | 200 | 138 | 7 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-06 | 200 | 138 | 7 | 310c75e13be9194312a8b686804edcf13d44caf5 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.06e-06 | 200 | 138 | 7 | c37fe06a94e5779c56e01389869bb432d3bbaebc | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 138 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 3.12e-06 | 129 | 138 | 6 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.88e-06 | 134 | 138 | 6 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|World / Lineage, cell class and subclass | 5.04e-06 | 80 | 138 | 5 | 9bd3ad5029eb84efcdbf08fe268c29fa9b0b302b | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-06 | 145 | 138 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.36e-06 | 146 | 138 | 6 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.88e-06 | 148 | 138 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.32e-06 | 153 | 138 | 6 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.04e-05 | 159 | 138 | 6 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-05 | 165 | 138 | 6 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 168 | 138 | 6 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-05 | 168 | 138 | 6 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 169 | 138 | 6 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | 15-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 1.52e-05 | 170 | 138 | 6 | 61f8dd5e27df1b8d01ccfd0d25247b34aa8d182c | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-05 | 170 | 138 | 6 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-05 | 170 | 138 | 6 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 171 | 138 | 6 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 171 | 138 | 6 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-05 | 172 | 138 | 6 | 4f2303dee1f816093e580ea8a4a8d7e3e4f36368 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-05 | 172 | 138 | 6 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 173 | 138 | 6 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.67e-05 | 173 | 138 | 6 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 177 | 138 | 6 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 178 | 138 | 6 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.03e-05 | 179 | 138 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-05 | 179 | 138 | 6 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 180 | 138 | 6 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 180 | 138 | 6 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.16e-05 | 181 | 138 | 6 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.23e-05 | 182 | 138 | 6 | 193cb2df3d7ea4cb9a11390b92955e7d9b0a053a | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.30e-05 | 183 | 138 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 184 | 138 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 184 | 138 | 6 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 184 | 138 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 184 | 138 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.37e-05 | 184 | 138 | 6 | 8ed22b1af04a711203293e7a8b3df6fb9222fad5 | |
| Drug | Nf279 | 2.18e-08 | 15 | 138 | 5 | CID000004467 | |
| Drug | suramin | 5.59e-07 | 207 | 138 | 10 | CID000005360 | |
| Drug | Ip5I | 6.16e-07 | 12 | 138 | 4 | CID004186342 | |
| Drug | AC1O718G | 6.16e-07 | 12 | 138 | 4 | CID000644357 | |
| Drug | AC1L1DKE | 1.01e-06 | 55 | 138 | 6 | CID000002388 | |
| Drug | Ado-5'-PP[S | 1.70e-06 | 60 | 138 | 6 | CID005310995 | |
| Drug | Ap6A | 2.47e-06 | 36 | 138 | 5 | CID000123694 | |
| Drug | Adenosine Triphosphate | 2.80e-06 | 193 | 138 | 9 | ctd:D000255 | |
| Drug | AC1L1IO7 | 5.00e-06 | 72 | 138 | 6 | CID000000194 | |
| Drug | Nf023 | 5.81e-06 | 20 | 138 | 4 | CID005311313 | |
| Drug | DMPX | 1.06e-05 | 48 | 138 | 5 | CID000099562 | |
| Drug | NSC-270916 | 1.07e-05 | 82 | 138 | 6 | CID000002949 | |
| Drug | AC1NE3ZR | 1.74e-05 | 26 | 138 | 4 | CID004636208 | |
| Drug | NSC243805 | 2.03e-05 | 27 | 138 | 4 | CID000316274 | |
| Drug | NSC36900 | 2.27e-05 | 56 | 138 | 5 | CID000235484 | |
| Drug | YO-PRO-1 | 2.36e-05 | 28 | 138 | 4 | CID006439500 | |
| Drug | 8-SPT | 2.47e-05 | 57 | 138 | 5 | CID000001908 | |
| Drug | purine riboside 5'-monophosphate | 2.53e-05 | 10 | 138 | 3 | CID000350833 | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 4407_UP | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 1693_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HG-U133A | 2.98e-05 | 199 | 138 | 8 | 426_UP | |
| Drug | C75; Up 200; 10uM; MCF7; HT_HG-U133A | 2.98e-05 | 199 | 138 | 8 | 6394_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A | 3.08e-05 | 200 | 138 | 8 | 3760_UP | |
| Drug | Ip(5)I | 3.47e-05 | 11 | 138 | 3 | CID006324651 | |
| Drug | (2S)-N-[4-(aminomethyl)-1,1-dioxothian-4-yl]-2-[1-(benzenesulfonamido)ethylideneamino]-3-(1-methylcyclopentyl)propanamide | 3.65e-05 | 2 | 138 | 2 | CID011840931 | |
| Drug | AC1L1K12 | 3.71e-05 | 102 | 138 | 6 | CID000005292 | |
| Drug | methylglucamine | 3.73e-05 | 62 | 138 | 5 | CID000004049 | |
| Drug | 8-phenyltheophylline | 3.73e-05 | 62 | 138 | 5 | CID000001922 | |
| Drug | AC1O5RSQ | 4.07e-05 | 32 | 138 | 4 | CID006439501 | |
| Drug | CH2OH | 4.61e-05 | 33 | 138 | 4 | CID000137654 | |
| Drug | Lopac-P-178 | 5.43e-05 | 67 | 138 | 5 | CID005478935 | |
| Drug | 2-methylthioadenosine triphosphate | 5.84e-05 | 68 | 138 | 5 | CID000001581 | |
| Drug | SPDP | 7.31e-05 | 37 | 138 | 4 | CID000100682 | |
| Drug | 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate | 7.55e-05 | 14 | 138 | 3 | ctd:C033901 | |
| Drug | DPCPX | 8.01e-05 | 117 | 138 | 6 | CID000001329 | |
| Drug | Ozone | SELE VWF MYOM1 UNC5B NAP1L4 CR1L CR2 LDLR IFIT3 CD163 TXN IVNS1ABP FASN PLPP1 ADAMTS9 SPON1 PLAU MUC5AC WDFY1 EPHA3 | 8.49e-05 | 1273 | 138 | 20 | ctd:D010126 |
| Drug | 1,3-dipropylxanthine | 8.76e-05 | 74 | 138 | 5 | CID000169317 | |
| Drug | Etiocobalamin | 1.05e-04 | 177 | 138 | 7 | CID006450878 | |
| Drug | AC1NDX9E | 1.10e-04 | 41 | 138 | 4 | CID004633079 | |
| Drug | AC1L1DDL | 1.20e-04 | 79 | 138 | 5 | CID000002304 | |
| Drug | sumatriptan | 1.27e-04 | 80 | 138 | 5 | CID000005358 | |
| Drug | bromouridine | 1.33e-04 | 43 | 138 | 4 | CID000091494 | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.34e-04 | 184 | 138 | 7 | 7295_UP | |
| Drug | butylphen | 1.39e-04 | 17 | 138 | 3 | ctd:C006862 | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.43e-04 | 186 | 138 | 7 | 6675_UP | |
| Drug | Atorvastatin Calcium | 1.43e-04 | 186 | 138 | 7 | ctd:D000069059 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 3.65e-07 | 4 | 134 | 3 | EFO_0803292 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 9.10e-07 | 5 | 134 | 3 | DOID:3030 (is_marker_for) | |
| Disease | Atypical hemolytic-uremic syndrome | 7.54e-06 | 9 | 134 | 3 | cv:C2931788 | |
| Disease | Hemolytic-uremic syndrome | 7.54e-06 | 9 | 134 | 3 | cv:C0019061 | |
| Disease | Age related macular degeneration | 1.02e-05 | 30 | 134 | 4 | C0242383 | |
| Disease | primary dental caries | 1.70e-05 | 34 | 134 | 4 | EFO_0600095 | |
| Disease | c3d:C3 ratio | 2.05e-05 | 2 | 134 | 2 | EFO_0008543 | |
| Disease | cystitis (is_marker_for) | 2.05e-05 | 2 | 134 | 2 | DOID:1679 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | RTP1 VWF VPS39 OBSCN PHF7 CUBN TECTA MDM4 TXN FASN OTOGL CD40 TENM1 PLEKHA8 PLXNB1 TP53BP2 | 3.09e-05 | 1074 | 134 | 16 | C0006142 |
| Disease | end stage renal disease (is_implicated_in) | 3.61e-05 | 41 | 134 | 4 | DOID:783 (is_implicated_in) | |
| Disease | endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase measurement | 6.12e-05 | 3 | 134 | 2 | EFO_0801568 | |
| Disease | anaphase-promoting complex subunit 7 measurement | 6.12e-05 | 3 | 134 | 2 | EFO_0801381 | |
| Disease | HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 | 6.12e-05 | 3 | 134 | 2 | C2749604 | |
| Disease | HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 | 6.12e-05 | 3 | 134 | 2 | 235400 | |
| Disease | calnexin measurement | 6.12e-05 | 3 | 134 | 2 | EFO_0801444 | |
| Disease | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 6.12e-05 | 3 | 134 | 2 | cv:C2749604 | |
| Disease | sputum mucin-5B amount | 6.12e-05 | 3 | 134 | 2 | OBA_2050332 | |
| Disease | bcl-2-like protein 2 measurement | 6.12e-05 | 3 | 134 | 2 | EFO_0021928 | |
| Disease | complement factor H-related protein 4A measurement | 6.12e-05 | 3 | 134 | 2 | EFO_0600057 | |
| Disease | chronic obstructive pulmonary disease (implicated_via_orthology) | 6.12e-05 | 3 | 134 | 2 | DOID:3083 (implicated_via_orthology) | |
| Disease | histone-lysine N-methyltransferase 2D measurement | 6.12e-05 | 3 | 134 | 2 | EFO_0801683 | |
| Disease | coagulation factor measurement | 9.87e-05 | 20 | 134 | 3 | EFO_0004634 | |
| Disease | endoglin measurement | 1.22e-04 | 4 | 134 | 2 | EFO_0008118 | |
| Disease | Meningococcal Infections | 1.22e-04 | 4 | 134 | 2 | C0025303 | |
| Disease | kallikrein-5 measurement | 1.22e-04 | 4 | 134 | 2 | EFO_0020515 | |
| Disease | neuritic plaque measurement | 2.02e-04 | 349 | 134 | 8 | EFO_0006798 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 2.03e-04 | 5 | 134 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | lysophosphatidylcholine acyltransferase 2 measurement | 2.03e-04 | 5 | 134 | 2 | EFO_0801775 | |
| Disease | non-word reading | 2.50e-04 | 67 | 134 | 4 | EFO_0005299 | |
| Disease | aspartate aminotransferase measurement | CFH THSD7A OBSCN NAP1L4 THSD7B TNFRSF10B CUBN CD163 STN1 CFHR3 CROT ADAMTS9 PCDHGB4 | 2.51e-04 | 904 | 134 | 13 | EFO_0004736 |
| Disease | complement C1s subcomponent measurement | 3.03e-04 | 6 | 134 | 2 | EFO_0008091 | |
| Disease | TNF-related apoptosis-inducing ligand measurement | 3.29e-04 | 72 | 134 | 4 | EFO_0008300 | |
| Disease | L-Selectin measurement | 3.75e-04 | 31 | 134 | 3 | EFO_0008202 | |
| Disease | anosmin-1 measurement | 4.24e-04 | 7 | 134 | 2 | EFO_0802284 | |
| Disease | atherosclerosis (implicated_via_orthology) | 4.24e-04 | 7 | 134 | 2 | DOID:1936 (implicated_via_orthology) | |
| Disease | Complement deficiency disease | 4.52e-04 | 33 | 134 | 3 | C0272242 | |
| Disease | IGA Glomerulonephritis | 4.94e-04 | 34 | 134 | 3 | C0017661 | |
| Disease | Nonsyndromic Deafness | 5.16e-04 | 81 | 134 | 4 | C3711374 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 5.63e-04 | 8 | 134 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | human immunodeficiency virus infectious disease (is_marker_for) | 5.86e-04 | 36 | 134 | 3 | DOID:526 (is_marker_for) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 7.22e-04 | 9 | 134 | 2 | EFO_0009824 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 7.22e-04 | 9 | 134 | 2 | EFO_0801766 | |
| Disease | colon cancer (biomarker_via_orthology) | 7.43e-04 | 39 | 134 | 3 | DOID:219 (biomarker_via_orthology) | |
| Disease | dilated cardiomyopathy (is_marker_for) | 7.43e-04 | 39 | 134 | 3 | DOID:12930 (is_marker_for) | |
| Disease | familial atrial fibrillation | 7.48e-04 | 156 | 134 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 7.48e-04 | 156 | 134 | 5 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 7.48e-04 | 156 | 134 | 5 | C0235480 | |
| Disease | Atrial Fibrillation | 8.38e-04 | 160 | 134 | 5 | C0004238 | |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0801544 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 8.99e-04 | 10 | 134 | 2 | C2931788 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 9.24e-04 | 42 | 134 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | External Carotid Artery Diseases | 1.10e-03 | 11 | 134 | 2 | C0600178 | |
| Disease | Internal Carotid Artery Diseases | 1.10e-03 | 11 | 134 | 2 | C0750986 | |
| Disease | Arterial Diseases, Common Carotid | 1.10e-03 | 11 | 134 | 2 | C0750987 | |
| Disease | Carotid Atherosclerosis | 1.10e-03 | 11 | 134 | 2 | C0577631 | |
| Disease | Carotid Artery Diseases | 1.10e-03 | 11 | 134 | 2 | C0007273 | |
| Disease | hemopexin measurement | 1.10e-03 | 11 | 134 | 2 | EFO_0008149 | |
| Disease | interleukin-22 receptor subunit alpha-2 measurement | 1.10e-03 | 11 | 134 | 2 | EFO_0020500 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 1.10e-03 | 11 | 134 | 2 | C1335302 | |
| Disease | Multiple Sclerosis | 1.13e-03 | 45 | 134 | 3 | C0026769 | |
| Disease | Multiple Sclerosis, Acute Fulminating | 1.13e-03 | 45 | 134 | 3 | C0751324 | |
| Disease | end stage renal disease (is_marker_for) | 1.21e-03 | 46 | 134 | 3 | DOID:783 (is_marker_for) | |
| Disease | Thrombus | 1.21e-03 | 46 | 134 | 3 | C0087086 | |
| Disease | complement factor H-related protein 4 measurement | 1.45e-03 | 49 | 134 | 3 | EFO_0600091 | |
| Disease | Thrombosis | 1.45e-03 | 49 | 134 | 3 | C0040053 | |
| Disease | colitis (implicated_via_orthology) | 1.55e-03 | 13 | 134 | 2 | DOID:0060180 (implicated_via_orthology) | |
| Disease | gastric ulcer (implicated_via_orthology) | 1.80e-03 | 14 | 134 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 2.07e-03 | 15 | 134 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | Proteinuria | 2.07e-03 | 15 | 134 | 2 | HP_0000093 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 2.07e-03 | 15 | 134 | 2 | EFO_0010367 | |
| Disease | Hypertrophic Cardiomyopathy | 2.24e-03 | 57 | 134 | 3 | C0007194 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 2.36e-03 | 16 | 134 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | Obesity | 2.49e-03 | 205 | 134 | 5 | C0028754 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 2.66e-03 | 17 | 134 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Malignant Neoplasms | 2.81e-03 | 128 | 134 | 4 | C0006826 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 2.85e-03 | 62 | 134 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.98e-03 | 63 | 134 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Age-related macular degeneration | 2.99e-03 | 18 | 134 | 2 | cv:C0242383 | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.12e-03 | 64 | 134 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Usual Interstitial Pneumonia | 3.33e-03 | 19 | 134 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 3.33e-03 | 19 | 134 | 2 | C4721508 | |
| Disease | squamous cell carcinoma (is_marker_for) | 3.33e-03 | 19 | 134 | 2 | DOID:1749 (is_marker_for) | |
| Disease | interstitial lung disease | 3.55e-03 | 67 | 134 | 3 | EFO_0004244 | |
| Disease | glaucoma (is_marker_for) | 3.69e-03 | 20 | 134 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 3.69e-03 | 20 | 134 | 2 | C4721952 | |
| Disease | Benign Neoplasm | 3.70e-03 | 68 | 134 | 3 | C0086692 | |
| Disease | Neoplasms | 3.70e-03 | 68 | 134 | 3 | C0027651 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 3.86e-03 | 227 | 134 | 5 | EFO_0004346, EFO_0010736 | |
| Disease | osteoarthritis (biomarker_via_orthology) | 4.06e-03 | 21 | 134 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 4.06e-03 | 21 | 134 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | Idiopathic Pulmonary Fibrosis | 4.06e-03 | 21 | 134 | 2 | C1800706 | |
| Disease | cardiovascular system disease (is_implicated_in) | 4.06e-03 | 21 | 134 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | complement factor H-like 1 protein measurement | 4.46e-03 | 22 | 134 | 2 | EFO_0600092 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CEACDQLGWTKPTKI | 36 | Q9H0S4 | |
| WKCCEDGTLELTDSN | 396 | P16452 | |
| EPWDGTTNESCCLVK | 156 | P29275 | |
| KPLSCGWEITDTLCV | 436 | Q96A70 | |
| ECHSSPKWEKDCQES | 316 | Q96GX5 | |
| VCSNEGKCICQPDWT | 691 | O75078 | |
| EEEWTCADFKCKLSP | 231 | Q9Y2T1 | |
| KDGWSAQPTCIKSCD | 496 | P08603 | |
| KCTITGLTFWDPSCE | 381 | P17813 | |
| KEPGESDCHLAEVWC | 36 | Q13625 | |
| LTGLDICSWKNEPCD | 386 | Q8TE57 | |
| ICSWKNEPCDTLGFA | 391 | Q8TE57 | |
| GFDICSWKNEPCDTL | 391 | Q8TE60 | |
| AASEWSECLVTCGKG | 1026 | P59510 | |
| LQPCKDCQTSWTSVF | 371 | Q6ZP01 | |
| VKTCEVAAWCPVEDD | 156 | Q99571 | |
| SWSCFQPGLCVKSES | 721 | Q9UN71 | |
| PDTCVWKGEGSFECA | 526 | Q8NAB2 | |
| ECEGKLPSLKIWETC | 51 | P01210 | |
| FCCTVGVDWKSLTTP | 736 | O75140 | |
| ACLDKGVCVDWRTPA | 1111 | Q6W4X9 | |
| GPEIVDCDGCTIDWK | 241 | Q99733 | |
| ADATIWKPDSCQSCR | 36 | Q86XX4 | |
| NSSCWFPHEGTKEIC | 521 | Q5T1H1 | |
| EDEWQCTECKKFNSP | 301 | O15151 | |
| NCDVFDPVTKLWTSC | 481 | Q9Y6Y0 | |
| CEPSPWTSCKSGAIE | 416 | Q6A163 | |
| SDTVECECSENWKGE | 266 | O75882 | |
| SSEDCKLQDLPPCWG | 316 | Q2LD37 | |
| PICDLSENGRDWKSC | 736 | Q8NDZ0 | |
| SLDWSPDKRGLCVCS | 326 | Q96MX6 | |
| PKADDCELCLESSWV | 1381 | Q92824 | |
| WELEEATLGASSCPC | 901 | O43157 | |
| STCHDKLDWLDDPCS | 561 | Q02817 | |
| CTSSGNWDNEKPTCK | 286 | P16581 | |
| GEWDNEKPTCEAVRC | 416 | P16581 | |
| SSVCQGEKSWVEEPC | 181 | P22413 | |
| KGETWATPNCSEATC | 4861 | P98088 | |
| SDSSCSPECLWEEGK | 291 | Q96JA3 | |
| SSWCSLTEGPECDVT | 86 | Q6UXL0 | |
| CVSTCKRNWSELPDE | 11 | O14753 | |
| VTWGDPELSCCDSST | 611 | Q16827 | |
| TCDIPVCWTKDGKTL | 3121 | Q5VST9 | |
| PSKTCEVFGWCPVED | 166 | Q9UBL9 | |
| EGNQKTCEVSAWCPI | 156 | Q99572 | |
| QWKGPLCSADVNECE | 161 | O60494 | |
| WVLCDSQGESCKEES | 196 | P36888 | |
| WCSEKTETGQELECL | 646 | Q92896 | |
| KEECSVTPCGQWKAL | 1231 | Q9P2N4 | |
| AEEWQECTKTCGEGS | 1561 | Q9P2N4 | |
| GWSAQPICINSSEKC | 196 | Q02985 | |
| KQPCEEETLGTCEEW | 1221 | Q9Y2F5 | |
| ECPETDCEKGWALLK | 136 | Q13325 | |
| QGTWEPSAPVCEKEC | 396 | P20023 | |
| WNSSVPVCERKSCET | 401 | Q2VPA4 | |
| SELDCEEGWTQLKCG | 136 | O14879 | |
| FLAAESWKPDVCTSC | 761 | Q9NZV1 | |
| EKLCVCNDSWQGPDC | 266 | Q5VV63 | |
| TEGEWLVPIGKCSCN | 246 | P29320 | |
| LWVSCANGQEVKPCD | 11 | Q92496 | |
| CTNEGSKENLVWCAT | 196 | Q96BH3 | |
| VAWQSKGDTPSSCCI | 86 | P50053 | |
| GDCPVQSGKTWQDCE | 81 | P01042 | |
| PDCKSLWNGDTGECT | 216 | P01042 | |
| WPSCCPSKGQDTSEE | 36 | Q9H293 | |
| AAVGLSWEECKQRCP | 621 | P49327 | |
| VKCKGNESSLWDCPA | 996 | Q86VB7 | |
| PEGDWFCPECEKITV | 121 | Q9ULU4 | |
| CDKTTPTGWTLDQCI | 76 | P12532 | |
| VACSAWKSCPETDAE | 576 | Q9UKG9 | |
| SWALGQCESPDETIK | 1106 | Q3ZCN5 | |
| CNSIPWVLGTCKETF | 111 | Q9UF33 | |
| VKTCEIFGWCPVEVD | 156 | P51575 | |
| CEACQEGIVHWKPSE | 191 | P59025 | |
| DSSCSPECLWEEGKE | 176 | O95397 | |
| GEECKVLPDLSGWSC | 106 | Q7Z5A8 | |
| TANLPEAHGCCWKTE | 151 | Q3SY00 | |
| WNVGLSAEDLCTKEC | 326 | Q9HCB6 | |
| GVDDSTGVINCICWK | 76 | Q9H668 | |
| PFCGEIDCEDWIKKT | 1446 | P07814 | |
| CAADPQWKTDSCQGD | 361 | P00749 | |
| SCEQKDCLASKPWDI | 641 | Q6ZMZ0 | |
| IPCQDDCQLTSWSKF | 901 | Q9UPZ6 | |
| NSKKWECEECSPAAA | 291 | Q9BWX1 | |
| VESEPSQWACKVCSA | 556 | P57071 | |
| LDVCDPDWSKINCSD | 131 | O14494 | |
| CVAEGGSDCAPEKLW | 201 | Q7LGA3 | |
| TFLLDAGVCSCDPKW | 671 | Q9UKZ4 | |
| KNCSPWLSCEELRTE | 66 | Q9H5K3 | |
| LESLNPTCTKACGIW | 1016 | Q7Z745 | |
| CQSDGNWDAEIPLCK | 2931 | Q4LDE5 | |
| PCIAVADKDSICFWD | 1036 | Q8N122 | |
| SELKSAEGSTWNCCP | 71 | Q8WXI8 | |
| KLVVVDFSATWCGPC | 21 | P10599 | |
| VEKDSVVCECRPGWT | 1346 | O75094 | |
| NSKLEVSCCAPWFQD | 351 | Q96JI7 | |
| WIEKENCSGVVEDPC | 1751 | O75443 | |
| DWCRDSKTAPSTNLC | 431 | Q5SXH7 | |
| DVDTWKSRCPISSCN | 541 | P98169 | |
| CSSPKWECTELIHDI | 361 | Q96HI0 | |
| GSWLECDDLKGPCSE | 466 | Q5W0Q7 | |
| TQQDSLSCPWECETK | 111 | P15622 | |
| LSCPWECETKGESQN | 116 | P15622 | |
| QETPEWLDSDSCQKC | 276 | Q96P53 | |
| QSPVKVEETCGCRWT | 1931 | P04275 | |
| WCSEEISHQQCPGKT | 151 | Q6ZMT1 | |
| TWESPKLHCQEINCG | 226 | Q6UWL2 | |
| ISSLGCWCGSKDEEA | 51 | Q96SQ5 | |
| ISSLGCWCGSKDEEA | 51 | Q8TAU3 | |
| WTTEEVETCDKGALC | 46 | Q9BY14 | |
| TCSRDDLVEKTPCAW | 86 | P28908 | |
| SCSRDDLVEKTPCAW | 261 | P28908 | |
| GVSSFCPEGEQWKCD | 961 | O15040 | |
| CPEGEQWKCDIVSER | 966 | O15040 | |
| KVGDCTPWSDIECVH | 166 | O14763 | |
| WDCDTCLVQNKPEAI | 726 | P49790 | |
| QKTACTTICPVDGAW | 291 | Q8IZJ1 | |
| VKVKDCTPWSDIECV | 216 | O00220 | |
| CTPWSDIECVHKESG | 221 | O00220 | |
| WSGAGKTTCCEQVLE | 661 | Q8IUG5 | |
| GCDRWITCKSLQPET | 51 | Q8IYP9 | |
| CEECGKAFNWPSTLT | 316 | P17038 | |
| VLDCGWIKPDICASN | 926 | Q8N9V7 | |
| CWCGVEDEAAPSKQS | 56 | E7ETH6 | |
| CEECGKAFIWPSTLT | 371 | A6NNF4 | |
| QDVDTWKSRCPISSC | 536 | P98168 | |
| CEECDKAFSWPSSLT | 1031 | O43345 | |
| EEESPWICSDCGKTF | 686 | A6NFI3 | |
| WCGVEDEAAPSKQSI | 56 | Q9H707 | |
| TEEPSVWCECGKSSS | 236 | Q9H707 | |
| KGLCSGWEPICETEE | 81 | Q96NI8 | |
| CWCGSEDEEAPSKKS | 46 | Q8TF45 | |
| SCTERDGWCLPKTSD | 431 | Q9Y5Q8 | |
| VVSEFLPWSNCSKGC | 181 | Q9C0I4 | |
| EAWAKDSGLVRCPEC | 41 | Q9BZR9 | |
| QTEGPCWCVDAQGKE | 331 | P01266 | |
| SSCICVTEKQQGSWP | 341 | Q08ET2 | |
| EEAPQWLESDSCQKC | 276 | Q8IWB7 | |
| LKWAPSGSSCCEIAQ | 276 | Q86Y07 | |
| CHPWTSCETKDLVVQ | 161 | P25942 | |
| VDSWCKACGEVDLPS | 461 | O75962 | |
| CWCGVEDEAAPSKQS | 56 | B7Z6K7 | |
| EEGICTQKCALNWTD | 231 | Q96JC1 | |
| DCRDWSDEPIKECGT | 301 | P01130 | |
| DDTGTCACKPTVTGW | 396 | Q9Y6N6 | |
| CIKANERCWAAESPE | 1571 | Q8NEV4 | |
| IDKCEVGTDSWSQCN | 546 | P52179 | |
| VGTDSWSQCNDTPVK | 551 | P52179 | |
| SECFKCEEWTIAVPG | 1026 | P52179 | |
| CLKCEISENIPGKWT | 451 | Q00872 |